Mineralys Therapeutics, Inc. Common Stock (MLYS) — Financial Flexibility Index
Mineralys Therapeutics, Inc. Common Stock (MLYS) has a Financial Flexibility Index of -2.68x as of March 2026. Free cash flow of $-39.47 Million (operating CF $-39.47 Million minus capex $0.00) represents -3% of total liabilities ($14.72 Million). Check Mineralys Therapeutics, Inc. Common Stoc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Mineralys Therapeutics, Inc. Common Stock Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Mineralys Therapeutics, Inc. Common Stock across 6 annual periods. See how liquid is Mineralys Therapeutics, Inc. Common Stoc's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Mineralys Therapeutics, Inc. Common Stock (2020–2025)
Year-by-year free cash flow to debt coverage for Mineralys Therapeutics, Inc. Common Stock. For the full company profile including market capitalisation, see MLYS company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -9.42x | $-142.40 Million | $-142.42 Million | $15.11 Million | ▲ +17.0% |
| 2024 | -11.35x | $-166.22 Million | $-166.31 Million | $14.65 Million | ▼ -46.6% |
| 2023 | -7.74x | $-81.17 Million | $-81.17 Million | $10.48 Million | ▼ -4318.1% |
| 2022 | -0.18x | $-29.22 Million | $-29.22 Million | $166.71 Million | ▲ +59.0% |
| 2021 | -0.43x | $-14.56 Million | $-14.56 Million | $34.05 Million | ▲ +11.8% |
| 2020 | -0.48x | $-2.46 Million | $-2.46 Million | $5.08 Million | — |